Научные интересы

Медицинская вирусология, экология вирусов, молекулярная эпидемиология, диагностики и профилактика вирусных гепатитов

Научные публикации

Gordeychuk I, Kyuregyan K, Kondrashova A, Bayurova E, Gulyaev S, Gulyaeva T, Potemkin I, Karlsen A, Isaeva O, Belyakova A, Lyashenko A, Sorokin A, Chumakov A, Morozov I, Isaguliants M, Ishmukhametov A, Mikhailov M. Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge. Vaccine. 2022 Jan 3;40(1):89-99. doi: 10.1016/j.vaccine.2021.11.042.
Slukinova OS, Kyuregyan KK, Karlsen AA, Potemkin IA, Kichatova VS, Semenov SI, Stepanov KM, Rumyantseva TD, Mikhailov MI. Serological Evidence of Hepatitis E Virus Circulation Among Reindeer and Reindeer Herders. Vector Borne Zoonotic Dis. 2021 Jul;21(7):546-551. doi: 10.1089/vbz.2020.2727.
Kyuregyan KK, Kichatova VS, Isaeva OV, Potemkin IA, Malinnikova EY, Lopatukhina MA, Karlsen AA, Asadi Mobarhan FA, Mullin EV, Slukinova OS, Ignateva ME, Sleptsova SS, Oglezneva EE, Shibrik EV, Isaguliants MG, Mikhailov MI. Coverage with Timely Administered Vaccination against Hepatitis B Virus and Its Influence on the Prevalence of HBV Infection in the Regions of Different Endemicity. Vaccines (Basel). 2021 Jan 23;9(2):82. doi: 10.3390/vaccines9020082.
Kartashova NP, Iarovenko SI, Glubokova EA, Potemkin IA, Karlsen AA, Leneva IA, Kyuregyan KK, Ryakhovskiy AA, Mikhailov MI. Optimization of a cellular HBV infection model for use in high-throughput drug screening. Acta Virol. 2021;65(1):82-88. doi: 10.4149/av_2021_110.
Mikhailov MI, Lopatukhina MA, Asadi Mobarhan FA, Ilchenko LY, Kozhanova TV, Isaeva OV, Karlsen AA, Potemkin IA, Kichatova VS, Saryglar AA, Oorzhak ND, Kyuregyan KK. Universal Single-Dose Vaccination against Hepatitis A in Children in a Region of High Endemicity. Vaccines (Basel). 2020 Dec 20;8(4):780. doi: 10.3390/vaccines8040780.
Kyuregyan KK, Kichatova VS, Karlsen AA, Isaeva OV, Solonin SA, Petkov S, Nielsen M, Isaguliants MG, Mikhailov MI. Factors Influencing the Prevalence of Resistance-Associated Substitutions in NS5A Protein in Treatment-Naive Patients with Chronic Hepatitis C. Biomedicines. 2020 Apr 7;8(4):80. doi: 10.3390/biomedicines8040080.
Dogadov DI, Korzaya LI, Kyuregyan KK, Karlsen AA, Kichatova VS, Potemkin IA, Goncharenko AM, Mikhailov MI, Lapin BA. Natural infection of captive cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus genotype 4. Arch Virol. 2019 Oct;164(10):2515-2518. doi: 10.1007/s00705-019-04337-3.
Kyuregyan KK, Malinnikova EY, Soboleva NV, Isaeva OV, Karlsen AA, Kichatova VS, Potemkin IA, Schibrik EV, Gadjieva OA, Bashiryan BA, Lebedeva NN, Serkov IL, Yankina A, Galli C, Mikhailov MI. Community screening for hepatitis C virus infection in a low-prevalence population. BMC Public Health. 2019 Aug 2;19(1):1038. doi: 10.1186/s12889-019-7388-7.
Dogadov DI, Korzaya LI, Karlsen AA, Kyuregyan KK. Molecular genetic identification of isolates of the hepatitis A virus (HAV) from monkeys at Adler Primate Center. J Med Primatol. 2018 Apr;47(2):87-92. doi: 10.1111/jmp.12333.
Kichatova VS, Kyuregyan KK, Soboleva NV, Karlsen AA, Isaeva OV, Isaguliants MG, Mikhailov MI. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context. J Immunol Res. 2018 Feb 7;2018:7685371. doi: 10.1155/2018/7685371.

Премии и награды

Медаль имени М.С. Балаяна за достижения в изучении гепатита Е (2019 г.)

Персональные профили исследователя

Web of Science: D-6300-2014
Scopus: 9245543000
РИНЦ: 5969-0249
ORCID: 0000-0002-3599-117X
MathSciNet: